NCT03792633View on ClinicalTrials.gov

Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions
Acute Lymphoblastic Leukemia
Interventions
BIOLOGICAL

huCART19

IV injection

Trial Locations (1)

19104

Children's Hospital of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

lead

University of Pennsylvania

OTHER

NCT03792633 - Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL | Biotech Hunter | Biotech Hunter